CCL3 and hepatocellular carcinoma: It was found that MASLD-HCC patients have higher plasma levels of IL-8, IL-13, chemokine (C–C motif) ligand (CCL-3), CCL-4, and CCL-5, which are correlated with activated circulating monocytes (Ponziani et al., 2019).